| Autor: |
Charles Agyemang, Manuela Deidda, Gershim Asiki, Shukri F Mohamed, Cindy M Gray, Christopher Bunn, Sally M Mtenga, Peter Binyaruka, Eleanor Grieve, Peter Kibe, Lyagamula Kisia, Patrick G Ilboudo, Richard E Sanya, Caroline H Karugu, Irene Mashiashi, F Mair |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
BMJ Public Health, Vol 2, Iss 2 (2024) |
| Druh dokumentu: |
article |
| ISSN: |
2753-4294 |
| DOI: |
10.1136/bmjph-2023-000383 |
| Popis: |
Introduction COVID-19 affected healthcare access, utilisation and affordability, especially for patients suffering from chronic diseases, including type 2 diabetes (T2D). This study measured the occurrence and magnitude of changes in healthcare and broader societal costs among patients with T2D before and during COVID-19 in Kenya and Tanzania to understand whether and how COVID-19 affected T2D management in countries implementing different policies during the pandemic.Methods A cross-sectional study was conducted in Kenya and Tanzania in March–April 2022 among 500 patients with T2D in each country. We interviewed patients on direct healthcare costs (eg, inpatient and outpatient costs), societal costs (eg, productivity loss) and patients’ characteristics before and during the COVID-19 pandemic. We estimated changes over time using the Generalised Linear Model in Kenya and a two-part model in Tanzania, adjusting for patient-level covariates.Results The overall costs of management of T2D in most categories increased in both countries during COVID-19, but some of the increase was not significant. Transport and testing costs increased significantly in Tanzania (I$0.33, p |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
